| Dr Kushal Yogi Mehta, MD | |
|
900 23rd St Nw, Washington, DC 20037-2342 | |
| (202) 714-5154 | |
| Not Available |
| Full Name | Dr Kushal Yogi Mehta |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 900 23rd St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194085118 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | D85176 (Maryland) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 0101264493 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Medical Center | Washington, DC | Hospital |
| Camden Clark Medical Center | Parkersburg, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Imaging Associates Of Dc Llc | 0244221299 | 11 |
| Washington Imaging Associates - Maryland Llc | 2264606094 | 12 |
| Maryland Imaging Network Pc | 6103259304 | 43 |
| Progressive Mri Llc | 8325042559 | 19 |
| Olney Open Mri Llc | 8325939127 | 14 |
| Progressive Mri Llc | 8325042559 | 19 |
| Progressive Mri Llc | 8325042559 | 19 |
| Washington Imaging Associates - Maryland Llc | 2264606094 | 12 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Washington Imaging Associates Of Dc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124003405 PECOS PAC ID: 0244221299 Enrollment ID: O20040519001213 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Olney Open Mri Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912044314 PECOS PAC ID: 8325939127 Enrollment ID: O20041030000242 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Progressive Mri Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689783185 PECOS PAC ID: 8325042559 Enrollment ID: O20090224000521 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Washington Imaging Associates - Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366634107 PECOS PAC ID: 2264606094 Enrollment ID: O20170510000059 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Maryland Imaging Network Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487296471 PECOS PAC ID: 6103259304 Enrollment ID: O20221130002395 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Entity Name | Southern Radiology Groups |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902518236 PECOS PAC ID: 5799159521 Enrollment ID: O20230320000026 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kushal Yogi Mehta, MD 3201 Jermantown Rd Ste 550, Fairfax, VA 22030-2885 Ph: (703) 667-8600 | Dr Kushal Yogi Mehta, MD 900 23rd St Nw, Washington, DC 20037-2342 Ph: (202) 714-5154 |
News Archive
Most people recognize that there is a relationship between cholesterol levels and risk of heart disease. But new research from Copenhagen University Hospital and University of Copenhagen shows that a certain kind of cholesterol might affect our health differently, that is, through a role in the immune system.
Aeolus Pharmaceuticals, Inc. announced today the initiation of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts.
Tumors that develop at the transition of the stomach to the esophagus, so-called adenocarcinomas of the gastroesophageal transition, are still difficult to treat and the chances of recovery are still low.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a collaboration with VLST Corporation to generate novel multi-antigen specific antibody therapeutics for the treatment of autoimmune and inflammatory disorders. This is the fourth collaboration announced by AnaptysBio during 2010.
› Verified 9 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |